Stablepharma
Chemicals & Related Products · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Queen St, Bath, Bristol, BA1 1HE, Unit...Phone Number
+44 1225581220Website
www.stablepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Stablepharma
Stablepharma is a biotechnology company focused on revolutionizing the delivery of temperature-sensitive pharmaceutical products, particularly vaccines, through its innovative StablevaX platform. This technology reformulates vaccines and pharmaceuticals into thermostable forms that remain effective at temperatures of 40°C and above, significantly reducing reliance on the traditional cold chain. By addressing the high rate of wastage during distribution and storage, Stablepharma aims to enhance global health access and reduce greenhouse gas emissions associated with the pharmaceutical supply chain. Their target clients include healthcare providers and organizations involved in immunization efforts and pharmaceutical distribution.Explore more
Stablepharma Org Chart
BH
Senior Medical Representative
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stablepharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Stablepharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Stablepharma recently announced quarterly report
Check if Stablepharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Stablepharma launches new products
Stablepharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Stablepharma
Funding: Get notified immidiatlly once Stablepharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Stablepharma is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Stablepharma
Compare insights from companies similar to Stablepharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stablepharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stablepharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stablepharma.
Stablepharma Tech Stack
A closer look at the technologies used by Stablepharma
See more technologies
Stablepharma News & Media
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics marketUK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
Following MHRA approval, Stablepharma has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02.Stablepharma: €2.5 Million Awarded For Advancing Pharmaceutical Technology
UK-based biotechnology firm Stablepharma announced it has been awarded €2.5 million through the European Innovation Council (EIC) Accelerator program. This grant recognizes the company’s fridge-free pharmaceutical technology, which meets EIC’s rigorous criteria for excellence, impact, and risk management.Stablepharma Receives €2.5M EIC Accelerator Grant
Stablepharma, a London, UK-based biotechnology firm, received a €2.5M grant through the EIC Accelerator Program. Led by Ozgur Tuncer, CEO & Executive Director, and Dr. Steve Chatfield, Non-Executive Chairman, Stablepharma has developed StablevaX™, the technology platform that transforms approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration. This innovation addresses the […] The post Stablepharma Receives €2.5M EIC Accelerator Grant appeared
Read more news
Top Chemicals & Related Products Companies
See more top companies
Frequently Asked Questions Regarding Stablepharma
Sign Up For FreeTo access detailed company insights
Stablepharma is a biotechnology company focused on revolutionizing the delivery of temperature-sensitive pharmaceutical products, particularly vaccines, through its innovative StablevaX platform. This technology reformulates vaccines and pharmaceuticals into thermostable forms that remain effective at temperatures of 40°C and above, significantly r... Read More
